How did PTIX's R&D expenses trend in Q4 2024?

Protagenic (PTIX) saw a significant increase in R&D expenses in Q4 2024, with the figure reaching $903,362. This represents a notable rise from the previous quarter, indicating a strong commitment to research and development during the period.